Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

SB-204269 in phase I for epilepsy

May 17, 1996

Ketoconazole: Potential treatment for depression?

May 17, 1996

Scios to copromote venlafaxine with Wyeth-Ayerst

May 17, 1996

5-HT1D antagonists disclosed by SmithKline Beecham

May 17, 1996

Pfizer claims 5-HT1 agonists and antagonists for CNS disorders

May 17, 1996

Sertindole clinical trial results reported at APA meeting

May 17, 1996

NIH scientists report ligands for alpha5-containing GABA-A receptors

May 17, 1996

Paroxetine approved for new indication

May 17, 1996

Kappa-opioid agonists reported by Pfizer

May 17, 1996

Pfizer claims analgesic bradykinin antagonists

May 17, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 13, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for May 13, 2025.
Little bite from voluntary most-favored nation Rx pricing order
BioWorld
After a week of hype, the most-favored nation (MFN) drug pricing executive order (EO) U.S. President Donald Trump signed May 12 has a lot of bark but little bite,...
AACR 2025: Induced proximity strategy, beyond degraders
BioWorld
Targeted protein degradation has yet to notch its first approval. But with more than two dozen agents now in clinical trials, the strategy’s ultimate clinical...
China’s NMPA gives thumbs up to Remegen’s ADC targeting HER2
BioWorld
China’s National Medical Products Administration has approved Remegen Co. Ltd.’s antibody-drug conjugate (ADC), disitamab vedotin (RC-48), for treatment of...